Literature DB >> 30944148

Forkhead box O1 (FOXO1) controls the migratory response of Toll-like receptor (TLR3)-stimulated human mesenchymal stromal cells.

Sun Hwa Kim1, Amitabh Das2, Hae In Choi3, Ki Hoon Kim1, Jin Choul Chai1, Mi Ran Choi2, Bert Binas1, Kyoung Sun Park2, Young Seek Lee1, Kyoung Hwa Jung4, Young Gyu Chai5,3.   

Abstract

Mesenchymal stromal cells (MSCs) can potently regulate the functions of immune cells and are being investigated for the management of inflammatory diseases. Toll-like receptor 3 (TLR3)-stimulated human MSCs (hMSCs) exhibit increased migration and chemotaxis within and toward damaged tissues. However, the regulatory mechanisms underlying these migratory activities are unclear. Therefore, we analyzed the migration capability and gene expression profiles of TLR3-stimulated hMSCs using RNA-Seq, wound healing, and transwell cell migration assay. Along with increased cell migration, the TLR3 stimulation also increased the expression of cytokines, chemokines, and cell migration-related genes. The promoter regions of the latter showed an enrichment of putative motifs for binding the transcription factors forkhead box O1 (FOXO1), FOXO3, NF-κB (NF-κB1), and RELA proto-oncogene and NF-κB subunit. Of note, FOXO1 inhibition by the FOXO1-selective inhibitor AS1842856 significantly reduced both migration and the expression of migration-related genes. In summary, our results indicate that TLR3 stimulation induces hMSC migration through the expression of FOXO1-activated genes.
© 2019 Hwa Kim et al.

Entities:  

Keywords:  RNA-sequencing; Toll-like receptor (TLR); cell migration; forkhead box protein O; gene expression; mesenchymal stem cells (MSCs); polyinosinic:polycytidylic acid; transcriptomics

Mesh:

Substances:

Year:  2019        PMID: 30944148      PMCID: PMC6544856          DOI: 10.1074/jbc.RA119.008673

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

Review 1.  Immunosuppressive properties of mesenchymal stem cells: advances and applications.

Authors:  M P De Miguel; S Fuentes-Julián; A Blázquez-Martínez; C Y Pascual; M A Aller; J Arias; F Arnalich-Montiel
Journal:  Curr Mol Med       Date:  2012-06       Impact factor: 2.222

Review 2.  Recognition and signaling by toll-like receptors.

Authors:  A Phillip West; Anna Alicia Koblansky; Sankar Ghosh
Journal:  Annu Rev Cell Dev Biol       Date:  2006       Impact factor: 13.827

3.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.

Authors:  Da Wei Huang; Brad T Sherman; Richard A Lempicki
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

Review 4.  Mechanisms of mesenchymal stromal cell immunomodulation.

Authors:  Karen English
Journal:  Immunol Cell Biol       Date:  2012-10-23       Impact factor: 5.126

5.  Characterization of mesenchymal stem cells under the stimulation of Toll-like receptor agonists.

Authors:  Xi Chen; Zheng-Yun Zhang; Hao Zhou; Guang-Wen Zhou
Journal:  Dev Growth Differ       Date:  2014-03-19       Impact factor: 2.053

6.  Multilineage potential of adult human mesenchymal stem cells.

Authors:  M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

7.  Human umbilical cord mesenchymal stem cells delivering sTRAIL home to lung cancer mediated by MCP-1/CCR2 axis and exhibit antitumor effects.

Authors:  Cihui Yan; Xinmiao Song; Wenwen Yu; Feng Wei; Hui Li; Mengguo Lv; Xinwei Zhang; Xiubao Ren
Journal:  Tumour Biol       Date:  2016-01-05

8.  Toll-like receptor 3 ligand polyinosinic:polycytidylic acid promotes wound healing in human and murine skin.

Authors:  Qing Lin; Li Wang; Youkun Lin; Xialin Liu; Xiangrong Ren; Sijian Wen; Xiaolin Du; Tao Lu; Sarah Y Su; Xiaoping Yang; Wenlin Huang; Shiyou Zhou; Feng Wen; Shao Bo Su
Journal:  J Invest Dermatol       Date:  2012-05-10       Impact factor: 8.551

9.  FoxO1 regulates allergic asthmatic inflammation through regulating polarization of the macrophage inflammatory phenotype.

Authors:  Sangwoon Chung; Tae Jin Lee; Brenda F Reader; Ji Young Kim; Yong Gyu Lee; Gye Young Park; Manjula Karpurapu; Megan N Ballinger; Feng Qian; Luiza Rusu; Hae Young Chung; Terry G Unterman; Carlo M Croce; John W Christman
Journal:  Oncotarget       Date:  2016-04-05

10.  Transcriptome sequencing wide functional analysis of human mesenchymal stem cells in response to TLR4 ligand.

Authors:  Sun Hwa Kim; Amitabh Das; Jin Choul Chai; Bert Binas; Mi Ran Choi; Kyoung Sun Park; Young Seek Lee; Kyoung Hwa Jung; Young Gyu Chai
Journal:  Sci Rep       Date:  2016-07-22       Impact factor: 4.379

View more
  3 in total

1.  BET inhibitor suppresses migration of human hepatocellular carcinoma by inhibiting SMARCA4.

Authors:  Hae In Choi; Ga Yeong An; Mina Baek; Eunyoung Yoo; Jin Choul Chai; Young Seek Lee; Kyoung Hwa Jung; Young Gyu Chai
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

2.  Epigenetic regulation of IFITM1 expression in lipopolysaccharide-stimulated human mesenchymal stromal cells.

Authors:  Sun Hwa Kim; Hae In Choi; Mi Ran Choi; Ga Yeong An; Bert Binas; Kyoung Hwa Jung; Young Gyu Chai
Journal:  Stem Cell Res Ther       Date:  2020-01-07       Impact factor: 6.832

Review 3.  Novel insights for improving the therapeutic safety and efficiency of mesenchymal stromal cells.

Authors:  Mehdi Najar; Johanne Martel-Pelletier; Jean Pierre Pelletier; Hassan Fahmi
Journal:  World J Stem Cells       Date:  2020-12-26       Impact factor: 5.326

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.